We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Breath Test Detects Vitamin B12 Levels

By LabMedica International staff writers
Posted on 29 Jun 2011
Diagnosis of vitamin B12 deficiency can be made using a simple, noninvasive, low-cost breath test.

Scientists have developed a test to detect the levels of vitamin B12 using a person's breath, allowing for a cheaper, faster diagnosis that could help to avoid the potentially fatal symptoms of B12 deficiency. More...


Vitamin B12 plays a crucial role in the breakdown of a common preservative called sodium propionate in bakery products, into carbon dioxide. Therefore, investigators decided to administer propionate to subjects, which would be broken down with the aid of vitamin B12 in the body, and then measure the resultant carbon dioxide.

The initial testing of the B12 breath test conducted measurements on subjects with chronic pancreatitis, Crohn's disease, and small intestinal bacterial overgrowth, as well as patients over 65, all of which are associated with a higher incidence of vitamin B12 deficiency.

After fasting and not smoking for 8 hours, the study participants were orally administered 50 mg of propionate and then tested every 10 minutes for the first hour and every 15 minutes for the second hour, with the best diagnostic accuracy appearing to be the 10- and 20-minute intervals.

To ascertain the accuracy of the breath test, the obtained vitamin B12 levels were compared with several blood compounds that are currently used to ascertain vitamin B12 deficiency. The results indicated that the vitamin B12 breath test is a noninvasive, sensitive, specific, and reproducible diagnostic test to detect vitamin B12 deficiency.

Lead author Dr. David Wagner said, "Initially, larger studies must be conducted including treatment of B12 deficient subjects showing resolution of the abnormal breath test results. If these results are positive, FDA approval with many study centers will need to be conducted."

The test was developed by scientists from the University of Florida at Gainesville (FL, USA) and Metabolic Solutions, Inc. (Nashua, NH, USA).

The study was published on June 23, 2011, in IOP Publishing's Journal of Breath Research.

Related Links:
University of Florida, Gainesville
Metabolic Solutions, Inc.


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.